| Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. | |
| | |
MedLine Citation:
|
PMID: 14687145 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: We aimed to determine the prevalence of significant alcohol intake in previously diagnosed nonalcoholic fatty liver (NAFL) patients. METHODS: We measured current and total lifetime alcohol intake (TLAI) in biopsy-proven NAFL patients using the cognitive lifetime drinking history (CLDH), a computerized questionnaire. One nurse administered the CLDH without physician presence. Physicians took alcohol histories prior to any knowledge of this study. Advanced and nonadvanced fibrosis patients were tested. A single pathologist (ST) scored all biopsies (inflammation 0-6; fibrosis 0-4). RESULTS: Twenty-three patients (11 men) were studied. Thirteen had bridging fibrosis or cirrhosis. [mean age: 52.3 yr (range 28-69); mean body mass index (BMI): 37 kg/m2 (range 27-48.6)]. All but three had hyperlipidemia, diabetes, and/or hypertension. Mean TLAI was 60.2 kg (range 0.17-471.7), but three patients were above 100 kg (threshold for cirrhosis risk) at 305.5, 336.7, and 471.7. These three had inflammation/fibrosis scores of 3/3, 3/0, and 5/2, respectively. Those with >100 kg tended to have higher serum AST and inflammation score. Prior physician-obtained alcohol history determined <or=20 g/day for all patients and did not mention TLAI in any. CLDH confirmed <or=20 g/day current alcohol intake in 21 of 23 patients, but intakes were 30.2 g/day and 41.2 g/day in two. CONCLUSIONS: Some NAFL patients may have alcohol fatty liver disease instead. Routine physician interviews obtain less accurate alcohol histories compared to CLDH. The clinical significance of past alcohol intake and methods of measuring alcohol ingestion in fatty liver patients deserves further investigation. |
| | |
Authors:
|
Paul H Hayashi; Stephen A Harrison; Sigurd Torgerson; Tammy A Perez; Thomas Nochajski; Marcia Russell |
Related Documents
:
|
3740655 - Quantitative aspects of lung pathology in cystic fibrosis. 20920895 - Abnormal electrochemical skin conductance in cystic fibrosis. 8453165 - Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. 8792955 - Dornase in treatment of chronic bronchitis. 21821335 - High value of combined serum c-reactive protein and bode score for mortality prediction... 23016875 - Association of overtime urine volume and ultrafiltration changes with patient survival ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The American journal of gastroenterology Volume: 99 ISSN: 0002-9270 ISO Abbreviation: Am. J. Gastroenterol. Publication Date: 2004 Jan |
Date Detail:
|
Created Date: 2003-12-22 Completed Date: 2004-02-05 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0421030 Medline TA: Am J Gastroenterol Country: United States |
Other Details:
|
Languages: eng Pagination: 76-81 Citation Subset: IM |
Affiliation:
|
Wilford Hall Medical Center, Gastroenterology and Pathology Departments, Brooke Army Medical Center, San Antonio, Texas, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Alcohol Drinking* / adverse effects Fatty Liver / diagnosis, pathology* Fatty Liver, Alcoholic / diagnosis, pathology Female Humans Liver / pathology Male Medical History Taking Middle Aged |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 i...
Next Document: Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's dise...